News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
855,479 Results
Type
Article (87061)
Company Profile (704)
Press Release (767699)
Multimedia
Podcasts (156)
Webinars (21)
Section
Business (232910)
Career Advice (4134)
Deals (39771)
Drug Delivery (131)
Drug Development (91151)
Employer Resources (200)
FDA (18215)
Job Trends (17376)
News (397029)
Policy (39859)
Tag
Academia (3002)
Academic (2)
Accelerated approval (15)
Adcomms (33)
Allergies (111)
Alliances (56978)
ALS (123)
Alzheimer's disease (1620)
Antibody-drug conjugate (ADC) (193)
Approvals (18183)
Artificial intelligence (421)
Autoimmune disease (39)
Automation (22)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (139)
Biotechnology (482)
Bladder cancer (109)
Brain cancer (44)
Breast cancer (416)
Cancer (3293)
Cardiovascular disease (263)
Career advice (3544)
Career pathing (34)
CAR-T (218)
CDC (43)
Cell therapy (602)
Cervical cancer (26)
Clinical research (74598)
Collaboration (1183)
Company closure (4)
Compensation (789)
Complete response letters (42)
COVID-19 (2919)
CRISPR (71)
C-suite (417)
Cystic fibrosis (126)
Data (3359)
Decentralized trials (2)
Denatured (56)
Depression (84)
Diabetes (390)
Diagnostics (7012)
Digital health (26)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (195)
Drug pricing (163)
Drug shortages (36)
Duchenne muscular dystrophy (171)
Earnings (98431)
Editorial (51)
Employer branding (25)
Employer resources (169)
Events (131731)
Executive appointments (933)
FDA (20265)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (1059)
Gene editing (154)
Generative AI (42)
Gene therapy (475)
GLP-1 (964)
Government (5308)
Grass and pollen (7)
Guidances (322)
Healthcare (20921)
HIV (47)
Huntington's disease (32)
IgA nephropathy (48)
Immunology and inflammation (198)
Immuno-oncology (15)
Indications (43)
Infectious disease (3126)
Inflammatory bowel disease (171)
Inflation Reduction Act (13)
Influenza (80)
Intellectual property (141)
Interviews (813)
IPO (17910)
IRA (58)
Job creations (5194)
Job search strategy (2863)
Kidney cancer (15)
Labor market (63)
Layoffs (612)
Leadership (27)
Legal (10141)
Liver cancer (87)
Longevity (12)
Lung cancer (456)
Lymphoma (234)
Machine learning (16)
Management (65)
Manufacturing (500)
MASH (106)
Medical device (14774)
Medtech (14785)
Mergers & acquisitions (22637)
Metabolic disorders (1001)
Multiple sclerosis (107)
NASH (23)
Neurodegenerative disease (166)
Neuropsychiatric disorders (48)
Neuroscience (2435)
NextGen: Class of 2025 (7687)
Non-profit (5092)
Now hiring (52)
Obesity (508)
Opinion (298)
Ovarian cancer (108)
Pain (136)
Pancreatic cancer (136)
Parkinson's disease (208)
Partnered (26)
Patents (353)
Patient recruitment (206)
Peanut (55)
People (65867)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (23007)
Phase II (32383)
Phase III (24396)
Pipeline (2177)
Policy (264)
Postmarket research (3554)
Preclinical (10397)
Press Release (72)
Prostate cancer (160)
Psychedelics (46)
Radiopharmaceuticals (279)
Rare diseases (554)
Real estate (7403)
Recruiting (76)
Regulatory (27407)
Reports (63)
Research institute (2667)
Resumes & cover letters (650)
Rett syndrome (10)
RNA editing (13)
RSV (62)
Schizophrenia (111)
Series A (176)
Series B (127)
Service/supplier (30)
Sickle cell disease (69)
Special edition (22)
Spinal muscular atrophy (168)
Sponsored (38)
Startups (4309)
State (2)
Stomach cancer (17)
Supply chain (86)
Tariffs (77)
The Weekly (98)
Vaccines (956)
Venture capital (62)
Weight loss (347)
Women's health (53)
Worklife (20)
Date
Today (132)
Last 7 days (714)
Last 30 days (2627)
Last 365 days (33835)
2025 (21018)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1278)
Alabama (73)
Alaska (7)
Arizona (287)
Arkansas (14)
Asia (50641)
Australia (8896)
California (8350)
Canada (2544)
China (763)
Colorado (357)
Connecticut (372)
Delaware (224)
Europe (116273)
Florida (1248)
Georgia (284)
Hawaii (3)
Idaho (67)
Illinois (767)
India (35)
Indiana (407)
Iowa (19)
Japan (250)
Kansas (118)
Kentucky (34)
Louisiana (20)
Maine (74)
Maryland (1164)
Massachusetts (6353)
Michigan (284)
Minnesota (516)
Mississippi (4)
Missouri (109)
Montana (32)
Nebraska (26)
Nevada (91)
New Hampshire (75)
New Jersey (2311)
New Mexico (31)
New York (2301)
North Carolina (1297)
North Dakota (10)
Northern California (3658)
Ohio (267)
Oklahoma (17)
Oregon (48)
Pennsylvania (1780)
Puerto Rico (18)
Rhode Island (42)
South America (1654)
South Carolina (39)
South Dakota (1)
Southern California (3136)
Tennessee (136)
Texas (1281)
United States (31264)
Utah (244)
Virginia (226)
Washington D.C. (80)
Washington State (722)
West Virginia (4)
Wisconsin (89)
There are 855,479 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Events
Register: Driving Biopharma Engagement: How Thought Leadership and Marketing Fuel Lead Generation
Establishing trust through thought leadership is no longer optional in today’s cautious biopharma market. This webinar will show leaders how strategic insights and targeted outreach can turn awareness into high-converting leads.
August 14, 2025
Drug pricing
Lilly Aims To Raise Europe Drug Prices in Response to Trumps’ Most Favored Nation Policy
As Trump has pressured drugmakers to lower the cost of medicines in the U.S., the pharma industry has coalesced behind a message of rebalancing what nations pay to better reflect the innovation and value of drugmaking.
August 14, 2025
·
3 min read
·
Annalee Armstrong
Obesity
Eli Lilly Keeps Obesity Pipeline Fresh With $1.3B Superluminal Partnership
The Boston-based AI/ML startup focuses on endocrine and cardiometabolic diseases and will use that expertise to generate new small molecule obesity medications for Lilly.
August 14, 2025
·
1 min read
·
Dan Samorodnitsky
Layoffs
WARN Act 101: How It Actually Works
WARN notices provide a heads up that staff will soon be unemployed, but the act that mandates them has some nuances. An attorney explains how the law works, common misconceptions about it and how it helps those about to lose their jobs.
August 14, 2025
·
5 min read
·
Angela Gabriel
Press Releases
Hemostemix’s Expands its Marketing Team Focused on Sales in Florida
August 14, 2025
·
9 min read
Press Releases
PharmaTher Founder and CEO Issues Letter to Shareholders Following the FDA Approval of Ketamine (KETARx(TM))
August 14, 2025
·
6 min read
Press Releases
Entero Therapeutics, Inc. Announces Reverse Stock Split
August 14, 2025
·
4 min read
Editorial
RFK Jr. Creates More Vaccine Misinformation With mRNA Cancellations
The HHS secretary recently canceled $500 million worth of BARDA contracts around mRNA vaccine research. But the U.S. government has already spent billions on this work, which has saved millions of lives.
August 14, 2025
·
4 min read
·
Dan Samorodnitsky
Press Releases
U.S. Cell And Gene Therapy Clinical Trials Market Size Expected to Hit USD 14.68 Billion by 2034
August 14, 2025
·
1 min read
Pipeline
Schrödinger Cans Early-Stage Blood Cancer Drug After Two Patient Deaths
After two patients who received the investigational CDC7 blocker died, pushing forward with SGR-2921’s development would be “difficult,” according to Schrödinger, whose stock dropped
17.5%
before the opening bell on Thursday.
August 14, 2025
·
2 min read
·
Tristan Manalac
1 of 85,548
Next
